Pricing
  1. JP-listed companies
  2. JMS CO.,LTD.
  3. Financials
  4. Cost of revenue

JMS CO.,LTD.【JP:7702】

Market cap
¥11.1B
P/E ratio
-13.7x
JMS manufactures and sells medical devices and pharmaceuticals globally, serving healthcare markets across Asia, Europe and the Americas.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCost of revenue (Million JPY)YoY (%)
Mar 31, 202553,824+5.13%
Mar 31, 202451,198+4.18%
Mar 31, 202349,145+11.95%
Mar 31, 202243,899+3.33%
Mar 31, 202142,483-1.04%
Mar 31, 202042,931-0.71%
Mar 31, 201943,240+2.37%
Mar 31, 201842,238+2.67%
Mar 31, 201741,139-3.81%
Mar 31, 201642,769+1.96%
Mar 31, 201541,948

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)